• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Extracorporeal Membrane Oxygenation Machine Companies

    ID: MRFR/HC/6647-HCR
    95 Pages
    Rahul Gotadki
    October 2025

    Extracorporeal Membrane Oxygenation (ECMO) is a life support system that provides temporary respiratory and cardiac support to patients with severe heart or lung failure. ECMO machines use a pump to circulate blood through an artificial lung (oxygenator) and return it to the patient, allowing the heart and lungs to rest and heal.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research Report - Global Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Extracorporeal Membrane Oxygenation Machine Market

    Extracorporeal Membrane Oxygenation Machine (ECMO) Key CompaniesLatest Extracorporeal Membrane Oxygenation Machine Companies Update

    July 2023: MGM Healthcare, a multi-specialty hospital, recently established a centralized pediatric and newborn ECMO center. The establishment of this centralized center serves as a representation of our steadfast commitment to providing state-of-the-art medical interventions, with a specific focus on ECMO, which stands as the ultimate form of life support for children facing grave illnesses. Through the establishment of this center, the organization reiterates its commitment to providing young patients with many opportunities for recuperation and a hopeful, flourishing future. Extracorporeal membrane oxygenation (ECMO) is a therapeutic intervention that involves the extracorporeal circulation of a child's blood using a mechanical device, which facilitates both oxygenation and pumping. This process enables the restoration of oxygen-rich blood to the child's body, therefore facilitating the recovery of cardiac and pulmonary functions.


    January 2023: the National Health Commission (NHC) of China officially authorized the introduction of the nation's first domestically produced extracorporeal membrane oxygenation (ECMO) equipment onto the market. The aforementioned equipment has been developed by Chinabridge Medical Technology Co. Ltd., which is a Sino-foreign joint company located in the southern Chinese city of Shenzhen. According to the official website of Chinabridge, the ECMO device is identified as the firm's primary product, with its development commencing at the establishment of the company in 2018. Extracorporeal membrane oxygenation (ECMO) has been included as a therapeutic modality in China's comprehensive strategy for managing and mitigating the impact of COVID-19.


    List of Extracorporeal Membrane Oxygenation Machine Key companies in the market

    • Getinge Group (sweden)

    • Medtronic plc (Ireland)

    • Livanova PLC (U.K)

    • Abbott, Agilent Technologies

    • Siemens AG

    • Terumo Corporation (Japan),

    • Fresenius Medical Care AG & Co. KGaA

    • Microport Scientific Corporation (China)

    • Nipro Corporation (Japan)

    • ALung Technologies Inc. (Germany)

    • MAQUET Holding B.V. & Co. KG

    • Medos Medizintechnik AG

    • Terumo Cardiovascular Systems Corp

    • XENIOS AG (Germany)

    • OriGen Biomedical, Inc. (U.S.)

    • EUROSETS S.r.l. (Italy)